Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

AVITA Medical (RCEL) Gross Margin (2018 - 2025)

AVITA Medical's Gross Margin history spans 8 years, with the latest figure at 15.56% for Q4 2025.

  • For Q4 2025, Gross Margin fell 7206.0% year-over-year to 15.56%; the TTM value through Dec 2025 reached 40.39%, down 4548.0%, while the annual FY2025 figure was 82.13%, 371.0% down from the prior year.
  • Gross Margin reached 15.56% in Q4 2025 per RCEL's latest filing, down from 82.12% in the prior quarter.
  • In the past five years, Gross Margin ranged from a high of 87.61% in Q4 2024 to a low of 15.56% in Q4 2025.
  • Average Gross Margin over 5 years is 79.7%, with a median of 83.68% recorded in 2024.
  • Peak YoY movement for Gross Margin: skyrocketed 778bps in 2023, then crashed -7206bps in 2025.
  • A 5-year view of Gross Margin shows it stood at 84.5% in 2021, then increased by 1bps to 85.75% in 2022, then grew by 2bps to 87.35% in 2023, then rose by 0bps to 87.61% in 2024, then crashed by -82bps to 15.56% in 2025.
  • Per Business Quant, the three most recent readings for RCEL's Gross Margin are 15.56% (Q4 2025), 82.12% (Q3 2025), and 82.02% (Q2 2025).